Unveiling the JETOUR T1's "Exploration DNA" through South America's Extreme Geography
GlobeNewswire
Today at 1:49am UTC
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Oracle Corporation Investors to Secure Counsel in Securities Class Action – ORCL
GlobeNewswire
Today at 1:46am UTC
Columbia University Names Jennifer L. Mnookin as Next President
PR Newswire
Today at 1:34am UTC
From Humanoid Robots to AI Seating: VivaNova Debuts "Active Health" Tech at imm cologne 2026
GlobeNewswire
Today at 1:32am UTC
INVESTIGATION ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
PR Newswire
Today at 1:24am UTC
INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
PR Newswire
Today at 1:22am UTC
INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
PR Newswire
Today at 1:21am UTC
INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Launches Investigation Into Wealthfront Following Post-IPO Stock Decline
PR Newswire
Today at 1:17am UTC
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds BellRing Brands Investors of Pending Class Action Lawsuit
PR Newswire
Today at 1:11am UTC
ROSEN, THE FIRST FILING FIRM, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class...
GlobeNewswire
Today at 1:04am UTC
Tulip Innovation Patent Claims Against Sunwoda Batteries Expand to Include KTC Action
PR Newswire
Today at 1:00am UTC
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Ardent Health, Inc. Investors to Secure Counsel Before Important Deadline in...
GlobeNewswire
Today at 12:45am UTC
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: The First FF EAI Robotics Product Has Completed U.S. Regulatory...
GlobeNewswire
Today at 12:30am UTC
Ascletis Announces First Participants Dosed in a 13-week U.S. Phase II Study with ASC30, an Oral Small Molecule GLP-1R Agonist for the...
PR Newswire
Today at 12:10am UTC
Argo Biopharma Announces First Patient Dosed in Phase 2b Trial of siRNA Therapeutic BW-20829 in Patients with Elevated Lp(a)
PR Newswire
Today at 12:00am UTC
The Billion Dollar Brushstroke: Attorney's art platform secures $1B+ in committed listings in first month - positioned for rapid growth.
PR Newswire
Today at 12:00am UTC
Hivemind Capital and CPIC Investment Management Announce Strategic Partnership to Establish $500 Million Real-World Asset Tokenization Fund
PR Newswire
Today at 12:00am UTC
Landmark FDA Move: First Quality Control Protocol for Mesenchymal Stromal Cells (MSCs) Sets New Therapeutic Standard
PR Newswire
Today at 12:00am UTC
DPC Dash-Domino's Pizza China Hits Symbolic Milestone: 1,405th Store Opens in Sanya, Matching Its HKEX Stock Ticker
PR Newswire
Today at 12:00am UTC
FDA Accepts LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of...
GlobeNewswire
Yesterday at 11:30pm UTC
  • <
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • ...
  • 19
  • 20
  • >